ClearPoint Neuro, Inc. (CLPT)
13.92
+0.17
(+1.24%)
USD |
NASDAQ |
Jun 11, 13:51
ClearPoint Neuro Total Assets (Quarterly) : 93.42M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 93.42M |
| December 31, 2025 | 100.89M |
| September 30, 2025 | 60.36M |
| June 30, 2025 | 62.87M |
| March 31, 2025 | 30.07M |
| December 31, 2024 | 39.19M |
| September 30, 2024 | 40.19M |
| June 30, 2024 | 52.57M |
| March 31, 2024 | 53.64M |
| December 31, 2023 | 42.66M |
| September 30, 2023 | 43.84M |
| June 30, 2023 | 47.64M |
| March 31, 2023 | 50.25M |
| December 31, 2022 | 55.49M |
| September 30, 2022 | 57.74M |
| June 30, 2022 | 60.24M |
| March 31, 2022 | 61.77M |
| December 31, 2021 | 65.58M |
| September 30, 2021 | 68.70M |
| June 30, 2021 | 72.33M |
| March 31, 2021 | 74.26M |
| December 31, 2020 | 29.52M |
| September 30, 2020 | 21.85M |
| June 30, 2020 | 23.03M |
| March 31, 2020 | 23.59M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.93M |
| September 30, 2019 | 13.39M |
| June 30, 2019 | 13.27M |
| March 31, 2019 | 7.626M |
| December 31, 2018 | 7.857M |
| September 30, 2018 | 8.678M |
| June 30, 2018 | 11.59M |
| March 31, 2018 | 12.35M |
| December 31, 2017 | 13.90M |
| September 30, 2017 | 15.46M |
| June 30, 2017 | 16.85M |
| March 31, 2017 | 6.191M |
| December 31, 2016 | 7.401M |
| September 30, 2016 | 9.014M |
| June 30, 2016 | 6.444M |
| March 31, 2016 | 8.292M |
| December 31, 2015 | 10.10M |
| September 30, 2015 | 6.273M |
| June 30, 2015 | 7.858M |
| March 31, 2015 | 10.75M |
| December 31, 2014 | 13.39M |
| September 30, 2014 | 6.505M |
| June 30, 2014 | 8.477M |
| March 31, 2014 | 10.05M |
| December 31, 2013 | 7.873M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CONMED Corp. | 2.315B |
| Integra LifeSciences Holdings Corp. | 3.578B |
| UFP Technologies, Inc. | 674.68M |
| CytoSorbents Corp. | 40.56M |
| Lucid Diagnostics, Inc. | 34.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 74.58M |
| Shareholders Equity (Quarterly) | 18.84M |
| Debt to Equity Ratio | 3.375 |
| Current Ratio | 5.789 |
| Net Debt Paydown Yield | -4.40% |